Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.65 -0.05 (-7.14%)
At close: Oct 23, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Sale and Maturity of Investments (2018 - 2025)

Updated

Analysis

Milestone Pharmaceuticals (MIST) Sale and Maturity of Investments (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Milestone Pharmaceuticals 80.92 Mn -89.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 10.00 Mn
Mar 31, 2025 34.47 Mn
Mar 31, 2021 12.00 Mn
Dec 31, 2020 16.00 Mn
Dec 31, 2019 30.00 Mn
Sep 30, 2019 5.00 Mn
Dec 31, 2018 3.01 Mn
Sep 30, 2018 983,000.00
Jun 30, 2018 8.03 Mn
Mar 31, 2018 7.00 Mn
API Access

Milestone Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=MIST&period=max&api_key=YOUR_API_KEY